Cargando…
HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment
BACKGROUND: The tumor microenvironment (TME) contains a variety of immune cells, which play critical roles during the multistep development of tumors. Histone deacetylase 9 (HDAC9) has been reported to have either proinflammatory or anti-inflammatory effects, depending on the immune environment. In...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304847/ https://www.ncbi.nlm.nih.gov/pubmed/32554611 http://dx.doi.org/10.1136/jitc-2020-000529 |
_version_ | 1783548341035991040 |
---|---|
author | Ning, Yongling Ding, Jun Sun, Xiao Xie, Yewen Su, Mingming Ma, Chenglong Pan, Jie Chen, Jie Jiang, Hua Qi, Chunjian |
author_facet | Ning, Yongling Ding, Jun Sun, Xiao Xie, Yewen Su, Mingming Ma, Chenglong Pan, Jie Chen, Jie Jiang, Hua Qi, Chunjian |
author_sort | Ning, Yongling |
collection | PubMed |
description | BACKGROUND: The tumor microenvironment (TME) contains a variety of immune cells, which play critical roles during the multistep development of tumors. Histone deacetylase 9 (HDAC9) has been reported to have either proinflammatory or anti-inflammatory effects, depending on the immune environment. In this study, we investigated whether HDAC9 in the tumor stroma regulated inflammation and antitumor immunity. METHODS: Hdac9 knockout mice were generated to analyze the HDAC9-associated inflammation and tumor progression. Immune cells and cytokines in TME or draining lymph nodes were quantified by flow cytometry and quantitative reverse transcription-PCR. The antigen presentation and CD8(+) T cell priming by tumor-infiltrating dendritic cells (DCs) were evaluated in vitro and in vivo. HDAC9-associated inflammation was investigated in a mouse model with dextran sulfate sodium–induced colitis. Correlation of HDAC9 with CD8(+) expression was assessed in tissue sections from patients with non-small cell lung cancer. RESULTS: HDAC9 deficiency promoted tumor progression by decreasing the CD8(+) DC infiltration of the TME. Compared with wild-type mice, the tumor-infiltrating DCs of Hdac9(-/-) mice displayed impaired cross-presentation of tumor antigens and cross-priming of CD8(+) T cells. Moreover, HDAC9 expression was significantly positively correlated with CD8(+) cell counts in human lung cancer stroma samples. CONCLUSIONS: HDAC9 deficiency decreased inflammation and promoted tumor progression by decreasing CD8(+) DC infiltration of the TME. HDAC9 expression in the tumor stroma may represent a promising biomarker to predict the therapeutic responses of patients receiving CD8(+) T cell-dependent immune treatment regimens. |
format | Online Article Text |
id | pubmed-7304847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73048472020-06-22 HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment Ning, Yongling Ding, Jun Sun, Xiao Xie, Yewen Su, Mingming Ma, Chenglong Pan, Jie Chen, Jie Jiang, Hua Qi, Chunjian J Immunother Cancer Basic Tumor Immunology BACKGROUND: The tumor microenvironment (TME) contains a variety of immune cells, which play critical roles during the multistep development of tumors. Histone deacetylase 9 (HDAC9) has been reported to have either proinflammatory or anti-inflammatory effects, depending on the immune environment. In this study, we investigated whether HDAC9 in the tumor stroma regulated inflammation and antitumor immunity. METHODS: Hdac9 knockout mice were generated to analyze the HDAC9-associated inflammation and tumor progression. Immune cells and cytokines in TME or draining lymph nodes were quantified by flow cytometry and quantitative reverse transcription-PCR. The antigen presentation and CD8(+) T cell priming by tumor-infiltrating dendritic cells (DCs) were evaluated in vitro and in vivo. HDAC9-associated inflammation was investigated in a mouse model with dextran sulfate sodium–induced colitis. Correlation of HDAC9 with CD8(+) expression was assessed in tissue sections from patients with non-small cell lung cancer. RESULTS: HDAC9 deficiency promoted tumor progression by decreasing the CD8(+) DC infiltration of the TME. Compared with wild-type mice, the tumor-infiltrating DCs of Hdac9(-/-) mice displayed impaired cross-presentation of tumor antigens and cross-priming of CD8(+) T cells. Moreover, HDAC9 expression was significantly positively correlated with CD8(+) cell counts in human lung cancer stroma samples. CONCLUSIONS: HDAC9 deficiency decreased inflammation and promoted tumor progression by decreasing CD8(+) DC infiltration of the TME. HDAC9 expression in the tumor stroma may represent a promising biomarker to predict the therapeutic responses of patients receiving CD8(+) T cell-dependent immune treatment regimens. BMJ Publishing Group 2020-06-17 /pmc/articles/PMC7304847/ /pubmed/32554611 http://dx.doi.org/10.1136/jitc-2020-000529 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Basic Tumor Immunology Ning, Yongling Ding, Jun Sun, Xiao Xie, Yewen Su, Mingming Ma, Chenglong Pan, Jie Chen, Jie Jiang, Hua Qi, Chunjian HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title | HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title_full | HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title_fullStr | HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title_full_unstemmed | HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title_short | HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment |
title_sort | hdac9 deficiency promotes tumor progression by decreasing the cd8(+) dendritic cell infiltration of the tumor microenvironment |
topic | Basic Tumor Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304847/ https://www.ncbi.nlm.nih.gov/pubmed/32554611 http://dx.doi.org/10.1136/jitc-2020-000529 |
work_keys_str_mv | AT ningyongling hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT dingjun hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT sunxiao hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT xieyewen hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT sumingming hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT machenglong hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT panjie hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT chenjie hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT jianghua hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment AT qichunjian hdac9deficiencypromotestumorprogressionbydecreasingthecd8dendriticcellinfiltrationofthetumormicroenvironment |